Evidence Reviews Now Available
Mobile Health Applications for Self-Management of Diabetes
(Systematic Review, released on May 8, 2018)
(Systematic Review, released on May 8, 2018)
Selected Key Messages:
- Although hundreds of apps for diabetes self-management are commercially available, we only identified health outcomes studies on 11 apps.
- Of the 11 apps, studies showed only 5 were associated with clinically significant improvements in HbA1c, an important clinical test for monitoring diabetes. (For Type 1 diabetes- Glucose Buddy, Diabeo Telesage; For Type 2 diabetes- Blue Star, WellTang, Gather Health)
- None of the studies showed patient improvements in quality of life, blood pressure, weight, or body mass index. More rigorous and longer-term research studies could determine whether apps help people manage their diabetes and reduce complications.
- Studies had methodological issues: they were short (2-12 months); inconsistent in reporting of randomization, allocation, masking, and drop-out analysis; and often used co-interventions that hindered interpretation of results. None of the included studies are considered to be high quality.
For more, see: https://effectivehealthcare. ahrq.gov/topics/diabetes- mobile-devices/technical-briefFor a related journal article, see: https://link.springer. com/article/10.1007/s11606- 018-4410-1
No hay comentarios:
Publicar un comentario